Cargando…
Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease
Sickle cell disease (SCD) is a group of inherited genetic conditions associated with lifelong complications and increased healthcare resource utilization. Standard treatment for SCD in the US varies based on stage of the disease and observed clinical severity. In this study, we aim to evaluate the p...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149675/ https://www.ncbi.nlm.nih.gov/pubmed/34035408 http://dx.doi.org/10.1038/s41598-021-90405-1 |